03/02
Headlines
Gilead Sciences GILD NASDAQ:GILD

4 Stock Touched New Lows: Body Central Corp (NASDAQ:BODY), RMG Networks Holding Corporation (NASDAQ:RMGN), KBR (NYSE:KBR), AMC Networks (NASDAQ:AMCX)

Colin Pettis02 mins

Body Central Corp. (NASDAQ:BODY) posted its quarterly earnings results on Wednesday. The company reported ($0.56) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.36) by $0.20, Analyst Ratings.Net reports. Body Central Corp (NASDAQ:BODY) stock performance was -36.98% in last session and finished the day at $ 0.600. Traded volume was 3.09 million…

Read More
FB Nasdaq FB Facebook

Stocks Touched New Highs: Globalstar, Inc. (NYSEMKT:GSAT), Ally Financial Inc (NYSE:ALLY), BP plc (ADR) (NYSE:BP), Walgreen Company (NYSE:WAG)

Kristen Barton02 mins

Globalstar, Inc. (NYSEMKT:GSAT)’s stock is rallying on Thursday despite the company missing first-quarter revenue estimates. By midday, shares had climbed 5.1% to $3.08. Trading volume of 5.8 million shares was nearly triple its three-month daily average. Globalstar, Inc. (NYSEMKT:GSAT) stock performance was 3.75% in last session and finished the day at $ 3.04. Traded volume…

Read More

Investor’s Watch List: Facebook Inc (NASDAQ:FB), Zynga Inc (NASDAQ:ZNGA), Twitter Inc (NYSE:TWTR), Nokia Corporation (ADR) (NYSE:NOK)

Kristen Barton02 mins

Facebook Inc (NASDAQ:FB) was upgraded by Credit Suisse from a “neutral” rating to an “outperform” rating in a research note issued on Wednesday, Stock Ratings Network.com reports. The firm currently has a $87.00 price objective on the stock, up from their previous price objective of $65.00. Facebook Inc (NASDAQ:FB) stock performance was -1.95% in last…

Read More

Nano Cap stocks in news: DARA Biosciences (NASDAQ:DARA), RXi Pharmaceuticals Corp (NASDAQ:RXII), Spherix Inc (NASDAQ:SPEX), Biodel Inc (NASDAQ:BIOD)

John Bellich02 mins

DARA Biosciences Inc (NASDAQ:DARA), an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising from their cancer treatment, today announced that Soltamox has been added to the Federal Supply Schedule for purchase by all government…

Read More

Tech News

Tech Analysis & Market News

Skip to content ↓